Wird geladen...

Biomarker-Oriented Therapy in Bladder and Renal Cancer

Treatment of patients with urothelial carcinoma (UC) of the bladder or renal cancer has changed significantly during recent years and efforts towards biomarker-directed therapy are being investigated. Immune checkpoint inhibition (ICI) or fibroblast growth factor receptor (FGFR) directed therapy are...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Mol Sci
Hauptverfasser: Scholtes, Mathijs P., Alberts, Arnout R., Iflé, Iris G., Verhagen, Paul C. M. S., van der Veldt, Astrid A. M., Zuiverloon, Tahlita C. M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2021
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7999814/
https://ncbi.nlm.nih.gov/pubmed/33799514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22062832
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!